Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 212-338-8 | CAS number: 791-28-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in chemico
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 29 October 2018 - 15 November 2018
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 018
- Report date:
- 2019
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 442C (In Chemico Skin Sensitisation: Direct Peptide Reactivity Assay (DPRA))
- Version / remarks:
- 04. Feb. 2015
- Deviations:
- yes
- Remarks:
- see "Part Results"
- Qualifier:
- according to guideline
- Guideline:
- other: EURL ECVAM (European Union Reference Laboratory for alternatives to animal testing): “DB-ALM Protocol n° 154: Direct Peptide Reactivity Assay (DPRA) for Skin Sensitisation Testing.”
- Version / remarks:
- 29. Jun. 2015
- Deviations:
- yes
- Remarks:
- see "Part Results"
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- direct peptide reactivity assay (DPRA)
Test material
- Reference substance name:
- Triphenylphosphine oxide
- EC Number:
- 212-338-8
- EC Name:
- Triphenylphosphine oxide
- Cas Number:
- 791-28-6
- Molecular formula:
- C18H15OP
- IUPAC Name:
- (diphenylphosphoroso)benzene
- Test material form:
- solid
Constituent 1
In chemico test system
- Details on the study design:
- Synthetic peptides:
Peptides with ≥ 95 % purity, synthesized by Genecust, Dudelange, Luxemburg, are used.
Sequence Cys-Peptide (Cysteine): Ac-RFAACAA-COOH (MW = 750.9 g/mol)
Sequence Lys-Peptide (Lysine): Ac-RFAAKAA-COOH (MW = 775.9 g/mol)
Instruments and Devices:
Components: Degasser G1322A
Quaternary pump G1311A
Autosampler G1313A
Column compartment G1316A
UV/VIS-Detector DAD G1315A
Heating chamber, Centrifuge, Fridge, Freezer, Repeater pipette, pH-meter, Analytical scale, Analytical scale, Pipette 100 – 1000 µL, Glass thermometer, Ultrasonic bath, Conductometer, Carbon analyser
Chemicals:
Water for chromatography
H2O, Honeywell, HPLC grade
Demineralised water
H2O, from ion exchange cartridge. Total organic carbon (TOC) < 1 ppm
Acetonitrile for chromatography
CH3CN, ACN, Honeywell, HPLC grade
CH3CN, ACN, AppliChem, analysis grade
Trifluoroacetic acid
TFA, Merck, for spectroscopy
Hydrochloric acid
HCl, 1 M, p.a.
Ammonium hydroxide
NH3,25 %, p.a.
Ammonium acetate,
CH3COONH4, p.a, Sigma Aldrich
Disodium hydrogen phosphate,
Na2HPO4 * 2 H2O, p.a., Carl Roth
Buffers:
25 mM Phosphate buffer
1.1105 g disodium hydrogen phosphate dihydrate were dissolved in demineralised water, pH was adjusted to 7.5 with 1 M HCl (final volume 250 mL).
25 mM Ammonium acetate
481.9 mg ammonium acetate (anhydrous) were dissolved in demineralised water, pH was adjusted to 10.2 with 25 % ammonium hydroxide (final volume 250 mL).
Positive control:
Cinnamaldehyde (CAS 104-55-2, food grade ≥ 95 %),100 mM solution in acetonitrile for the cysteine peptide
2,3-Butanedione (CAS 431-03-8, > 97 %), 100 mM solution in acetonitrile for the lysine peptide
As cinnamaldehyde mixed with the lysine peptide turned turbid in all experiments performed during the implementation phase, it was considered unsuitable as positive control. Instead, the proficiency chemical 2,3-Butanedione is used as positive control showing mid-range depletion for the lysine peptide.
Solvent controls
For both peptides, four sets of solvent controls using acetonitrile instead of test item stock solution were prepared in triplicate (sets A, B1, B2 and C, total 12 samples per peptide). Set A was analysed together with the peptide calibration standards, sets B1 and B2 were analysed at the start and end of the analysis sequence and were used as stability control for the peptide over the total analysis time. Set C was incubated and analysed together with the samples and was used for calculation of the peptide depletion.
Co-elution control
Sample prepared from the respective peptide buffer and the test item, but without peptide.
Peptide stock solutions
The peptide stock solutions were freshly prepared for each assay.
0.667 mM Cys-Peptide solution was prepared by dissolving 22.5 mg of the peptide in 45 mL phosphate buffer, pH 7.5.
0.667 mM Lys-Peptide solution was prepared by dissolving 23.3 mg of the peptide in 45 mL ammonium acetate buffer, pH 10.2.
0.667 mM Lys-Peptide solution was prepared by dissolving 18.1 mg of the peptide in 35 mL ammonium acetate buffer, pH 10.2. (experiment 2)
0.667 mM Lys-Peptide solution was prepared by dissolving 20.7 mg of the peptide in 40 mL ammonium acetate buffer, pH 10.2. (experiment 3)
Test item stock solution:
The test item stock solution is freshly prepared for each assay. 100 mM test item solution is prepared by dissolving 83.7 mg test item in 3 mL of the solvent acetonitrile for the Cys-Peptide and 83.7 mg test item for the Lys-peptide in experiment 1, respectively.
In experiment 2 and 3 the test item solution was prepared with 83.5 mg test item for the Lys-peptide measurement.
Peptide calibration standards:
From each peptide stock solution the following calibration standards were prepared in the appropriate dilution buffer: 0.534 / 0.267 / 0.134 / 0.067 / 0.033 / 0.017 mM peptide. Blank dilution buffer was also measured. Calibration samples were analysed before the samples containing the test item.
Test item samples:
Samples were prepared in triplicate for each peptide. The Cys-peptide samples were prepared in 1:10 molar ratio (0.5 mM peptide: 5 mM test item), the Lys-peptide samples in 1:50 molar ratio (0.5 mM peptide and 25 mM test item) using the stock solutions described. A final volume of 1 mL per sample was prepared for each sample.
Incubation:
The positive control, solvent control sets C, and test item samples were incubated in closed amber glass HPLC vials in an incubation chamber at 25.0 °C for 22 h and 25 min for the Cys-peptide and 22 h and 15 min for the Lys-peptide in experiment 1, respectively. In experiments 2 and 3 the incubation time was 22 h for the Lys-peptide. None of the Cys-peptide replicates were turbid after incubation in experiment 1. All three replicates for the Lys-peptide were turbid after incubation in experiment 1. They were centrifuged (10 min, 400 g) and only the clear supernatant was used for the measurement. In Experiment 2 and 3, none of the Lys-peptide replicates were turbid after incubation.
Measurements
HPLC system with UV/VIS-Detector
Evaluation of results:
Evaluation criteria of results according to the cysteine 1:10 / lysine 1:50 prediction model.
Mean peptide depletion [%] Reactivity Evaluation
> 42.47 high reactivity positive
> 22.62 ≤ 42.47 moderate reactivity positive
> 6.38 ≤ 22.62 low reactivity positive
0- ≤ 6.385 minimal or no reactivity negative
Evaluation criteria of results according to the cysteine 1:10 prediction model.
mean Cys peptide depletion [%] Reactivity Evaluation
> 98.24 - ≤ 100 high reactivity positive
> 23.09 ≤ 98.24 moderate reactivity positive
> 13.89 ≤ 23.09 low reactivity positive
0 - ≤ 13.89 minimal or no reactivity negative
Acceptance criteria
The standard calibration curve should have an r² > 0.99
The mean peptide concentration of solvent control samples of sets A and C should be 0.50 ± 0.05 mM
The variation coefficient (relative standard deviation, RSD) of measured values of the nine samples from sets B1, B2 and C should be < 15 %
The mean peptide depletion value for the positive control cinnamaldehyde should be 60.8 % - 100.0 % with a maximum standard deviation (SD) of < 14.9 % for the Cys-peptide.
The mean peptide depletion value for the positive control 2,3-butanedione should be 10.0 % - 45.0 % with a maximum standard deviation < 11.6 % for the Lys-peptide.
The standard deviation for the test item replicates should be < 14.9 % for the percent cysteine depletion and < 11.6 % for the percent lysine depletion.
Results and discussion
- Positive control results:
- see "Any other information on results incl. tables"
In vitro / in chemico
Resultsopen allclose all
- Key result
- Run / experiment:
- other: 1st experiment
- Parameter:
- other: mean peptide depletion for Cys-Peptide (%)
- Value:
- 1.39
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Run / experiment:
- other: 1st experiment
- Parameter:
- other: mean peptide depletion for Lys-Peptide (%)
- Value:
- 0
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Run / experiment:
- other: 2nd experiment
- Parameter:
- other: mean peptide depletion for Lys-Peptide (%)
- Value:
- 0
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Run / experiment:
- other: 3rd experiment
- Parameter:
- other: mean peptide depletion for Lys-Peptide (%)
- Value:
- 0
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Parameter:
- other: mean peptide depletion for both peptides (%)
- Value:
- 0.7
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Other effects / acceptance of results:
- OTHER EFFECTS:
- Visible damage on test system: No
DEMONSTRATION OF TECHNICAL PROFICIENCY:
The ten proficiency chemicals listed in the guideline were tested using the analysis method described. All ten proficiency chemicals showed the expected DPRA prediction and eight out of the ten chemicals showed depletion values consistent with the classification reported in the OECD guideline.
ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: Yes
- Acceptance criteria met for positive control: Yes
- Acceptance criteria met for variability between replicate measurements: Yes
Any other information on results incl. tables
Table 1: Calculated peptide depletion values for the Cys-Peptide
Sample name |
Depletion [%] |
||
Single |
Mean |
SD |
|
Positive control Rep. 1 |
89.40 |
89.74 |
0.30 |
Positive control Rep. 2 |
89.84 |
||
Positive control Rep. 3 |
89.99 |
||
Test item Rep. 1 |
0.54 |
1.39 |
1.05 |
Test item Rep. 2 |
1.07 |
||
Test item Rep. 3 |
2.57 |
Table 2: Calculated peptide depletion values for the Lys-Peptide in experiment 1
Sample name |
Depletion [%] |
||
Single |
Mean |
SD |
|
Positive control Rep. 1 |
44.02 |
46.48 |
2.49 |
Positive control Rep. 2 |
46.43 |
||
Positive control Rep. 3 |
49.00 |
||
Test item Rep. 1 |
0 (-0.7)* |
0.00 |
0.00 |
Test item Rep. 2 |
0 (-0.5)* |
||
Test item Rep. 3 |
0 (-1.08)* |
* Note: Negative depletion values were considered as “zero” when calculating the mean.
Table 3: Calculated peptide depletion values for the Lys-Peptide in experiment 2
Sample name |
Depletion [%] |
||
Single |
Mean |
SD |
|
Positive control Rep. 1 |
47.06 |
48.61 |
1.50 |
Positive control Rep. 2 |
48.71 |
||
Positive control Rep. 3 |
50.07 |
||
Test item Rep. 1 |
0 (-0.08)* |
0.00 |
0.00 |
Test item Rep. 2 |
0 (-0.03)* |
||
Test item Rep. 3 |
0 (-0.52)* |
* Note: Negative depletion values were considered as “zero” when calculating the mean.
Table 4: Calculated peptide depletion values for the Lys-Peptide in experiment 3
Sample name |
Depletion [%] |
||
Single |
Mean |
SD |
|
Positive control Rep. 1 |
44.72 |
47.16 |
2.49 |
Positive control Rep. 2 |
47.04 |
||
Positive control Rep. 3 |
49.71 |
||
Test item Rep. 1 |
0 (-0.71)* |
0.00 |
0.00 |
Test item Rep. 2 |
0 (-0.46)* |
||
Test item Rep. 3 |
0 (-0.93)* |
Table 5: Historical Control Data for the positive control item
Parameter |
Depletion [%] |
Depletion [%] |
Peptide |
Cys- Peptide |
Lys- Peptide |
Mean |
81.74 |
32.77 |
Standard |
8.48 |
3.99 |
Range 2σ |
64.82 – 98.71 |
24.79 - 40.74 |
Conducted study |
89.74 |
46.48 and 48.61 and 47.16 |
The following deviations of the guideline were observed:
The phosphate buffer used for dissolution of the Cys-peptide and the ammonium acetate buffer used for dissolution of the Lys-peptide in the experiments 1-3 were 25 mM instead of 100 mM. This was considered uncritical because the positive control confirmed that the buffer strength was sufficient.
The phosphate buffer used for dissolution of the Cys-peptide in experiment 1 was prepared by dissolving disodium hydrogen phosphate dihydrate and adjusting the pH by using 1 M HCl instead of using sodium dihydrogen phosphate monohydrate and disodium hydrogen phosphate heptahydrate in combination.This was considered uncritical because by dissolving disodium hydrogen phosphate in water, sodium dihydrogen ions are also formed and the pH was adjusted to the correct value.
The mean percent peptide-depletion of the positive control 2,3-butanedione was marginal out of range (the value was slightly too high) in the experiments 1, 2 and 3. This was considered uncritical, because it shows, that the test system was slightly too sensitive and even under these conditions the mean percent peptide-depletion of the test item showed a value for a clearly negative DPRA-prediction.
Table 6: Mean Peptide Depletion of both peptides
|
Cys-peptide |
Lys-peptide |
Mean peptide |
Experiment 1 |
1.39 |
0.00 |
0.70 |
Experiment 2 |
-* |
0.00 |
|
Experiment 3 |
-* |
0.00 |
*Note: in experiment 2 and 3, Cys-peptide was not performed, because a valid result was obtained in experiment 1.
Applicant's summary and conclusion
- Interpretation of results:
- other: no peptide depletion
- Conclusions:
- The DPRA prediction is “negative” with minimal reactivity according to the Cysteine 1:10/Lysine 1:50 prediction model. It can be stated that in this study and under the experimental conditions reported, the test item possesses no or minimal skin sensitisation potential.
- Executive summary:
A study according OECD TG 442C was performed in order to evaluate the reactivity of the test item towards cysteine (Cys-) and lysine (Lys-) containing peptides. A test item solution in acetonitrile and the respective peptide was incubated at 25 °C for 22 h and 25 min for the Cys-peptide and 22 h and 15 min for the Lys-peptide, in experiment 1 respectively. In experiments 2 and 3 the incubation time was 22 h for the Lys-peptide. The peptide concentration after the incubation was measured using HPLC-UV.
Three replicates were prepared using 1:10 and 1:50 molar ratio of the test item with the Cys- and Lys-peptide, respectively. Triplicate samples of the solvent without test item were incubated and measured simultaneously.
Experiment 1 was valid for the Cys-peptide. Within the measurement of the Lys-peptide the positive control 2,3-butanedione was marginal out of the range (the value was slightly too high).
In experiment 2 only the measurement of Lys-peptide was performed and the mean peptide-depletion of the positive control 2,3-butanedione was marginal out of the range (the value was slightly too high).
The third experiment was performed only for the Lys-peptide again and the mean peptide-depletion of the positive control 2,3-butanedione was marginal out of the range (the value was slightly too high).
In experiments 1, 2 and 3 the mean peptide-depletion of the positive control 2,3-butanedione was only marginal too high, what shows that the system was a little too sensitive.
Due to the fact, that the mean peptide-depletion of the test item shows values for a clearly negative DPRA-prediction, these experiments were considered as valid. The result from experiment 1 was confirmed by the experiments 2 and 3.
In conclusion, the DPRA prediction is “negative” with minimal reactivity according to the Cysteine 1:10/Lysine 1:50 prediction model. It can be stated that in this study and under the experimental conditions reported, the test item possesses no or minimal skin sensitisation potential.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.